1 May 2019
The number one drug in biosimilar clinical trials by count is adalimumab biosimilar, referencing the branded biologic Humira.
10 April 2019
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s Contract Service Provider Database.
3 April 2019
Biomarkers used in clinical studies may verify the mechanism of action of a drug, guide subject and dose selection and minimise patient safety risks.
15 March 2019
The results investigated the efficacy and safety of cabotegravir/rilpivirine, the company’s once-monthly injection for treating HIV.
11 February 2019
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP supplies for clinical trials
30 January 2019
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges of patient recruitment
28 January 2019
John Shillingford, Clinical Operations Director, Orsus Medical, describes the inherent challenges facing small- to mid-sized medical device companies
18 January 2019
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded information in clinical trials
16 January 2019
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations in Asia
14 January 2019
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on board newly acquired therapeutic assets